tiprankstipranks
Advertisement
Advertisement

HK:6622 Stock Latest News

Zhaoke Ophthalmology Shareholders Approve All Resolutions at 2026 AGM
Company AnnouncementsZhaoke Ophthalmology Shareholders Approve All Resolutions at 2026 AGM
6d ago
6622
Zhaoke Ophthalmology Renews Related-Party CMO Deal for Eyprotor
PremiumCompany Announcements
Zhaoke Ophthalmology Renews Related-Party CMO Deal for Eyprotor
21d ago
6622
Zhaoke Ophthalmology Sets 2026 AGM to Seek Share Repurchase and Issuance Mandates
PremiumCompany Announcements
Zhaoke Ophthalmology Sets 2026 AGM to Seek Share Repurchase and Issuance Mandates
28d ago
6622
Zhaoke Ophthalmology Moves to Update Articles for Hybrid Meetings and New HK Rules
PremiumCompany Announcements
Zhaoke Ophthalmology Moves to Update Articles for Hybrid Meetings and New HK Rules
1M ago
6622
Zhaoke Ophthalmology Narrows Core Loss as Revenue Halves in 2025
PremiumCompany Announcements
Zhaoke Ophthalmology Narrows Core Loss as Revenue Halves in 2025
2M ago
6622
Zhaoke Ophthalmology Schedules Board Meeting to Approve 2025 Annual Results
PremiumCompany AnnouncementsZhaoke Ophthalmology Schedules Board Meeting to Approve 2025 Annual Results
2M ago
6622
Zhaoke Ophthalmology Set to Accelerate Asia-Pacific Launch After Partner’s FDA Approval for Presbyopia Drug
Premium
Company Announcements
Zhaoke Ophthalmology Set to Accelerate Asia-Pacific Launch After Partner’s FDA Approval for Presbyopia Drug
4M ago
6622
Zhaoke Ophthalmology Expands BRIMOCHOL™ PF Presbyopia Push to Singapore and Vietnam
Premium
Company Announcements
Zhaoke Ophthalmology Expands BRIMOCHOL™ PF Presbyopia Push to Singapore and Vietnam
4M ago
6622
Zhaoke Ophthalmology’s Pediatric Myopia Drug Accepted for Evaluation by Australia’s TGA
PremiumCompany Announcements
Zhaoke Ophthalmology’s Pediatric Myopia Drug Accepted for Evaluation by Australia’s TGA
4M ago
6622
Zhaoke Ophthalmology Partners with TSH Biopharm for Taiwan Market Entry
PremiumCompany Announcements
Zhaoke Ophthalmology Partners with TSH Biopharm for Taiwan Market Entry
5M ago
6622
Zhaoke Ophthalmology Gains Key Approvals for Innovative Eye Treatments
PremiumCompany Announcements
Zhaoke Ophthalmology Gains Key Approvals for Innovative Eye Treatments
6M ago
6622
Zhaoke Ophthalmology Expands into Indonesia with New Distribution Agreement
PremiumCompany Announcements
Zhaoke Ophthalmology Expands into Indonesia with New Distribution Agreement
7M ago
6622
Zhaoke Ophthalmology Grants 8 Million Share Options to Boost Talent Retention
PremiumCompany AnnouncementsZhaoke Ophthalmology Grants 8 Million Share Options to Boost Talent Retention
9M ago
6622
Zhaoke Ophthalmology Reports Significant Revenue Decline and Increased Losses in H1 2025
Premium
Company Announcements
Zhaoke Ophthalmology Reports Significant Revenue Decline and Increased Losses in H1 2025
9M ago
6622
Zhaoke Ophthalmology Ltd. Schedules Board Meeting for Interim Results
Premium
Company Announcements
Zhaoke Ophthalmology Ltd. Schedules Board Meeting for Interim Results
9M ago
6622
Zhaoke Ophthalmology Secures Certification for Innovative Glaucoma Device
PremiumCompany Announcements
Zhaoke Ophthalmology Secures Certification for Innovative Glaucoma Device
10M ago
6622
Zhaoke Ophthalmology Secures FDA Orphan Drug Designation for Pediatric Eye Cancer Treatment
PremiumCompany Announcements
Zhaoke Ophthalmology Secures FDA Orphan Drug Designation for Pediatric Eye Cancer Treatment
10M ago
6622
Zhaoke Ophthalmology’s NVK002 Gains NMPA Acceptance for Myopia Treatment
PremiumCompany Announcements
Zhaoke Ophthalmology’s NVK002 Gains NMPA Acceptance for Myopia Treatment
11M ago
6622
Zhaoke Ophthalmology Updates Nomination Committee in Governance Code Compliance
PremiumCompany Announcements
Zhaoke Ophthalmology Updates Nomination Committee in Governance Code Compliance
11M ago
6622
Zhaoke Ophthalmology Announces Board Composition and Roles
PremiumCompany AnnouncementsZhaoke Ophthalmology Announces Board Composition and Roles
11M ago
6622
Zhaoke Ophthalmology Establishes Nomination Committee for Board Appointments
Premium
Company Announcements
Zhaoke Ophthalmology Establishes Nomination Committee for Board Appointments
11M ago
6622
Zhaoke Ophthalmology’s TAB014 BLA Accepted by China’s NMPA
Premium
Company Announcements
Zhaoke Ophthalmology’s TAB014 BLA Accepted by China’s NMPA
11M ago
6622

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >